An Inactivating Mutation in HDAC2 Leads to Dysregulation of Apoptosis Mediated by APAF1

Gastroenterology

Volumn 135, Issue 5, 2008, Pages

  Hanigan, Christin L ^a   van Engeland, Manon ^c   De Bruine, Adriaan P ^c   Wouters, Kim A ^c   Weijenberg, Matty P ^c   Eshleman, James R ^b   Herman, James G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; HISTONE DEACETYLASE 2; TRICHOSTATIN A; VORINOSTAT;

APOPTOSIS; ARTICLE; CANCER CELL; CAPILLARY ELECTROPHORESIS; COLON CANCER; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE LOSS; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; METHYLATION; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COLONIC NEOPLASMS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ELECTROPHORESIS, CAPILLARY; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; REPRESSOR PROTEINS;

EID: 55249098844     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.07.078     Document Type: Article

References (37)

1. Zhu P., Martin E., Mengwasser J., et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5 (2004) 455-463
2. Kernochan L.E., Russo M.L., Woodling N.S., et al. The role of histone acetylation in SMN gene expression. Hum Mol Genet 14 (2005) 1171-1182
3. Zupkovitz G., Tischler J., Posch M., et al. Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol Cell Biol 26 (2006) 7913-7928
4. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
5. Marks P.A., Richon V.M., and Rifkind R.A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92 (2000) 1210-1216
6. Zhu P., Huber E., Kiefer F., et al. Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis. Cell Cycle 3 (2004) 1240-1242
7. Ropero S., Fraga M.F., Ballestar E., et al. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet 38 (2006) 566-569
8. van Engeland M., Weijenberg M.P., Roemen G.M., et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63 (2003) 3133-3137
9. Weichert W., Roske A., Niesporke S., et al. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin Cancer Res 14 (2008) 1669-1677
10. Fahrner J.A., Eguchi S., Herman J.G., et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 62 (2002) 7213-7218
11. Suraweera N., Duval A., Reperant M., et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123 (2002) 1804-1811
12. Herman J.G., Graff J.R., Myohanen S., et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93 (1996) 9821-9826
13. Lassus P., Opitz-Araya X., and Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297 (2002) 1352-1354
14. Yang W.M., Yao Y.L., Sun J.M., et al. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J Biol Chem 272 (1997) 28001-28007
15. Berg K.D., Glaser C.L., Thompson R.E., et al. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2 (2000) 20-28
16. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., Meltzer S.J., Rodriguez-Bigas M.A., Fodde R., Ranzani G.N., et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
17. Esteller M., Levine R., Baylin S.B., et al. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17 (1998) 2413-2417
18. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
19. Herman J.G., Umar A., Polyak K., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95 (1998) 6870-6875
20. Goel A., Arnold C.N., Tassone P., et al. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer 112 (2004) 754-759
21. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 (2006) 787-793
22. Shen L., Kondo Y., Hamilton S.R., et al. P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 124 (2003) 626-633
23. Brandes J.C., van Engeland M., Wouters K.A., et al. CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype. Carcinogenesis 26 (2005) 1152-1156
24. Ogawa K., Yasumura S., Atarashi Y., et al. Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells. J Hepatol 40 (2004) 278-284
25. Peart M.J., Smyth G.K., van Laar R.K., et al. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci U S A 102 (2005) 3697-3702
26. Wang S., Yan-Neale Y., Cai R., et al. Activation of mitochondrial pathway is crucial for tumor selective induction of apoptosis by LAQ824. Cell Cycle 5 (2006) 1662-1668
27. Fesik S.W. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5 (2005) 876-885
28. Facchetti F., Previdi S., Ballarini M., et al. Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors. Apoptosis 9 (2004) 573-582
29. Cameron E.E., Bachman K.E., Myohanen S., et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21 (1999) 103-107
30. Markowitz S., Wang J., Myeroff L., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 (1995) 1336-1338
31. Rampino N., Yamamoto H., Ionov Y., et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275 (1997) 967-969
32. Lagger G., O'Carroll D., Rembold M., et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 21 (2002) 2672-2681
33. Wilson A.J., Byun D.S., Popova N., et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 281 (2006) 13548-13558
34. Shao Y., Gao Z., Marks P.A., et al. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 101 (2004) 18030-18035
35. Hrzenjak A., Moinfar F., Kremser M.L., et al. Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells. Mol Cancer Ther 5 (2006) 2203-2210
36. Huang X., and Guo B. Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. Cancer Res 66 (2006) 9245-9251
37. Kim Y.H., Park J.W., Lee J.Y., et al. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. Carcinogenesis 25 (2004) 1813-1820